PMPooja J. Mude

Pooja J. Mude

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Pooja J. Mude has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Pharmacy Intervention Matters: Improving the Quality of Care of Helicobacter pylori Treatment

    by Omar Soudan, Rand Soudan, Tara Koehler, Nimisha Vasandani, Apryl Cronley, Pooja J. Mude, Ahmad Alkaddour, Carlos Palacio, John Erikson L. Yap, Kenneth J. Vega

    Objectives: Helicobacter pylori (HP) infection has an estimated prevalence of ~4.4 billion individuals worldwide. Clinical manifestations range from asymptomatic to mucosa-associated lymphoid tissue lymphoma. Effective eradication depends on both appropriate treatment selection and patient adherence. The study aims were compare HP eradication rates, antibiotic regimen selection and confirmation testing between patients managed by a clinical pharmacist versus standard care. Methods: A retrospective review of adults diagnosed and treated for HP was performed between March 2019 and November 2021. Patients were divided into two sequential cohorts: a pre-pharmacy group receiving standard care, and a pharmacist intervention group in which a clinical pharmacist managed treatment and documented HP eradication. Data analyzed included multiple demographic and clinical factors. Eradication was assessed by intention-to-treat (ITT) and per-protocol analysis with proportions compared using chi-square or Fisher’s Exact Test for low cell counts. Results: A total of 134 patients were diagnosed and treated for HP during the study period: 38 in the pre-pharmacy group and 96 in the pharmacist intervention group. In ITT analysis, successful eradication did not differ significantly between groups. Per-protocol analysis revealed significantly higher eradication in the pharmacist group. Antibiotic regimens overall differed between the cohorts with less use of clarithromycin-based triple therapy and greater use of non-bismuth quadruple (concomitant) therapy in the pharmacist group. Other evaluated items were not significantly different between groups. Conclusions: Clinical pharmacist HP care management was associated with more consistent, guideline-concordant antibiotic regimen selection and higher eradication rates among patients completing confirmatory testing. These findings support a role for pharmacist-led HP care for process improvement including regimen selection and eradication testing; prospective studies with systematic confirmatory testing are needed to determine the model’s effect on eradication itself.

  • Open Access

    Human Intestinal Spirochetosis: A Rare Case of Intermittent Bloating and Hematochezia

    by Reinaldo L. Pérez Moux, Pooja Mude, Shreyans Doshi, Kiran Madwani, Amanda Barrett, John Erikson L. Yap

    Human intestinal spirochetosis (HIS) is a condition where spirochetes, a group of spiral-shaped bacteria, attach to the apical membrane of the human colorectal epithelium. Although most findings of HIS are simply incidental discoveries found during screening colonoscopies, the ability to mimic the presentation of inflammatory bowel diseases should prompt consideration of this condition as part of a working differential diagnosis. Herein, we present the case of a 57-year-old bisexual, African American male with a medical history of Human Immunodeficiency Virus (HIV) on antiretroviral therapy (ART) with an undetectable viral load that presented for an elective, outpatient colonoscopy after experiencing four months of intermittent bloating and hematochezia. Histologic examination of colonic biopsies confirmed a diagnosis of HIS. The nonspecific clinical presentation in the setting of well-controlled HIV makes HIS a formidable diagnostic challenge that requires increased awareness.


  • Open Access

    Severe Hypertriglyceridemia-Induced Necrotizing Pancreatitis Associated With Ketogenic Diet in a Well-Controlled Patient With Type 2 Diabetes Mellitus

    by Jacqueline T. Chan, Pooja J. Mude, Whitney Canfield, Jinal Makhija, John Erikson L. Yap

    The ketogenic diet (keto diet) has become an increasingly popular approach for both weight loss and as an alternative diet for type 2 diabetes mellitus (T2DM). Owing to the nature of the keto diet, patients are at risk of developing hypertriglyceridemia (HTG) due to the high amount of triglycerides consumed by individuals during the initiation of this diet. Acute pancreatitis can result from HTG. We present a case of a 19-year-old African American male with well-controlled T2DM and no history of HTG who developed severe necrotizing HTG-induced pancreatitis after an unsupervised three-month trial of the keto diet.